Fellowship · Houston, TX
Sponsored by University of Texas M D Anderson Cancer Center
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Leukemia · 2022 · 3,530 citations · Wei-Lien Wang
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Leukemia · 2022 · 3,300 citations · Alexander Lazar
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Cell · 2024 · 464 citations · Sinchita Chowdhuri
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
The New England journal of medicine · 2023 · 739 citations · Victor Prieto
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 841 citations · William Symmans
Bladder cancer.
Nature reviews. Disease primers · 2023 · 465 citations · Donna Hansel
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Science (New York, N.Y.) · 2021 · 792 citations · Alexander Lazar
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology · 2026 · 56 citations · William Symmans